ACHN - Achillion Pharmaceuticals, Inc.
We couldn't determine Recommendation based on the data we have.

Unless specified, all values are in USD Millions. Data extracted from SEC Filing and are subject to processing and input errors.
Achillion Pharmaceuticals, Inc. (ACHN) -
Achillion Pharmaceuticals, Inc. engages in the discovery and development of small molecule drug therapies for immune system disorders. It offers its propriety platform of potent and specific complement factor D inhibitors for AP-mediated diseases. The company was founded on August 17, 1998 and is headquartered in New Haven, CT.
Exchange - NASDAQ
Industry - Biotechnology
Sector - Health Technology
Employees - 56

Disclaimer - Investment in securities involves substantial risk and could result in significant loss. It is not suitable for every investor. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser. We may own some of the securities mentioned in this website.
Know the Stock © 2021 and future.